Lineage Cell Therapeutics LCTX Balance Sheet

Income Statement

Quarter End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	144.52M	135.92M	131.15M	123.66M	113.21M	111.69M	106.15M	101.02M
Total Current Assets	81.87M	74.03M	68.51M	60M	49.66M	48.49M	43.48M	38.44M
Cash and Equivalents	78.06M	70.86M	24.75M	11.36M	15.45M	33.89M	31.47M	35.44M
Total Non-Current Assets	67.2M	65.77M	67.29M	69.34M	69.13M	68.51M	67.53M	67.35M
Total Liabilities	59.3M	54.42M	53.6M	51.73M	44.19M	40.43M	39.49M	39M
Total Current Liabilities	24.59M	25.09M	22.74M	18.98M	17.23M	16.05M	15.88M	17.96M
Total Non-Current Liabilities	34.74M	29.35M	30.87M	32.83M	27.1M	24.49M	23.71M	21.13M
Common Equity	435.82M	437.15M	439.15M	440.28M	441.3M	448.25M	450.28M	451.34M
Retained Earnings	-344.18M	-350.95M	-357.02M	-363.37M	-367.74M	-372.97M	-380.08M	-384.86M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	142.57M	173.24M	101.66M	125.48M	107.95M	174.55M	123.66M	101.02M
Total Current Assets	25.65M	42.62M	36.36M	57.52M	44M	111.55M	60M	38.44M
Cash and Equivalents	22.09M	36.84M	23.59M	9.5M	32.59M	55.74M	11.36M	35.44M
Total Non-Current Assets	130.51M	164.26M	92.25M	111.25M	95.13M	90.9M	71.94M	62.02M
Total Liabilities	12.06M	8.98M	9.41M	14.23M	12.82M	83.65M	51.73M	39M
Total Current Liabilities	8.85M	6.88M	6.81M	6.49M	7.77M	47.12M	18.98M	17.96M
Total Non-Current Liabilities	6.06M	3.27M	4.56M	7.81M	5.08M	36.56M	32.83M	21.13M
Total Equity	130.51M	164.26M	92.25M	111.25M	95.13M	90.9M	71.94M	62.02M
Common Equity	317.88M	378.49M	354.27M	387.06M	393.94M	434.53M	440.28M	451.34M
Retained Earnings	-196.32M	-216.3M	-261.86M	-273.42M	-294.08M	-337.1M	-363.37M	-384.86M